Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7539711 | 0.82 | EPHX1 (0.34) | EPHX1MAPTAKR1C3AKR1C2 | |
| SCHEMBL7539055 | 0.82 | MAPT (0.34) | CYP1A2MAPTCYP2C9CYP2C19ERN1 | |
| SCHEMBL7538726 | 0.80 | MEN1 (0.39) | EPHX1MAPT | |
| SCHEMBL7538427 | 0.79 | WDR5 (0.50) | EPHX1CYP1A2MAPTCYP2C9CYP2C19 | |
| SCHEMBL7539732 | 0.69 | MAPT (0.36) | CYP1A2MAPTCYP2C9CYP2C19ERN1 | |
| SCHEMBL7545406 | 0.66 | DRD1 (0.35) | — | |
| SCHEMBL7535787 | 0.66 | DRD1 (0.39) | — | |
| SCHEMBL7542805 | 0.65 | MAPT (0.38) | CYP1A2MAPTCYP2C9CYP2C19ERN1 | |
| SCHEMBL7538784 | 0.62 | KDM4E (0.38) | MAPT | |
| SCHEMBL7537322 | 0.62 | SOS1 (0.41) | CYP1A2MAPTCYP2C9CYP2C19MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | S.C. JOHNSON & SON, INC. | 2002-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | ACHE, DDT, GAP43 | EPHX1 460/4885CYP1A2 1275/4885MAPT 3240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.